On the stock market since 2025, it operates in the world of money and finance. Now — the numbers.
The stock trades below its recent peak — about 12% off the top. A pullback, not a collapse.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
The stock sits at $0.23. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 1/100.
On our five-subject report card, CRANR sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CRANR is a high-risk stock — not yet profitable, and its future rides on its product catching on.